OSMOTIC STIMULATION AFFECTS NEUROHYPOPHYSEAL CORTICOTROPIN RELEASING FACTOR-41 CONTENT - EFFECT OF DEXAMETHASONE

被引:9
作者
DOHANICS, J
LINTON, EA
LOWRY, PJ
MAKARA, GB
机构
[1] HUNGARIAN ACAD SCI,INST EXPTL MED,H-1450 BUDAPEST,HUNGARY
[2] UNIV READING,DEPT PHYSIOL & BIOCHEM,READING RG6 2AJ,BERKS,ENGLAND
关键词
Arginine vasopressin; CRF-41; Dexamethasone; Neurointermediate lobe; Osmotic stimulation; Oxytocin;
D O I
10.1016/0196-9781(90)90109-I
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study we examined the effects of 2% saline loading (S), partial restriction of water consumption (R) or a combination of S or R with dexamethasone (DEX) treatment for 14 days on corticotropin releasing factor (CRF)-41 content of the neurointermediate lobe (NIL) and supraoptic nuclei (SON) of male Wistar rats. Arginine vasopressin (AVP) and oxytocin (OXY) contents of the NIL and SON were also assayed as well as plasma corticosterone, ACTH, [Na+] and [Cl-] concentrations. S or R for 14 days resulted in an increase in CRF-41 content and a concomitant drop in AVP and OXY contents of the NIL. Dexamethasone treatment enhanced the effect of S but not of R on NIL CRF-41 content. Dexamethasone treatment abolished the decrease in the AVP content and partially reversed the decrease in the OXY content of the NIL in response to S but not in response to R. No changes were observed in CRF-41, AVP and OXY content of the SON. Unstressed plasma corticosterone concentrations were not changed in S rats but were elevated in R rats; DEX did not prevent this elevation. Plasma ACTH concentrations were low in all groups examined. Plasma [Na+] and [Cl-] increased in response to both S and R. Increases in [Na+] and [Cl-] evoked by S but not R were prevented by DEX treatment. The results show that in the NIL, osmotic stimulation decreases AVP and OXY content, while it increases the CRF-41 content. © 1990.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 47 条
  • [1] ALZEIN M, 1984, NEUROENDOCRINOL LETT, V6, P151
  • [3] OXYTOCIN AS WELL AS VASOPRESSIN POTENTIATE OVINE CRF INVITRO
    ANTONI, FA
    HOLMES, MC
    JONES, MT
    [J]. PEPTIDES, 1983, 4 (04) : 411 - 415
  • [4] CORTICOTROPIN RELEASING-FACTOR (CRF) - IMMUNOREACTIVE NEURONS AND FIBERS IN RAT HYPOTHALAMUS
    BLOOM, FE
    BATTENBERG, ELF
    RIVIER, J
    VALE, W
    [J]. REGULATORY PEPTIDES, 1982, 4 (01) : 43 - 48
  • [5] INTRAVENOUS VASOPRESSIN INFUSION DECREASES PLASMA ACTH CONCENTRATION IN CONSCIOUS DOGS
    BROOKS, VL
    BLAKEMORE, LJ
    KEIL, LC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (04): : R665 - R671
  • [6] CORTICOTROPIN-RELEASING FACTOR RECEPTORS IN RAT PITUITARY-GLAND - AUTORADIOGRAPHIC LOCALIZATION
    DESOUZA, EB
    PERRIN, MH
    RIVIER, J
    VALE, WW
    KUHAR, MJ
    [J]. BRAIN RESEARCH, 1984, 296 (01) : 202 - 207
  • [7] ADRENAL STEROID INHIBITION OF VASOPRESSIN RELEASE FROM THE NEUROHYPOPHYSIS OF NORMAL SUBJECTS AND PATIENTS WITH ADDISONS DISEASE
    DINGMAN, JF
    DESPOINTES, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (12) : 1851 - 1863
  • [8] EVIDENCE FOR RELEASE OF VASOPRESSIN AND OXYTOCIN INTO CEREBROSPINAL-FLUID - MEASUREMENTS IN PLASMA AND CSF OF INTACT AND HYPOPHYSECTOMIZED RATS
    DOGTEROM, J
    VANWIMERSMAGREIDANUS, TB
    SWAAB, DF
    [J]. NEUROENDOCRINOLOGY, 1977, 24 (02) : 108 - 118
  • [9] DOHANICS J, 1987, Society for Neuroscience Abstracts, V13, P1371
  • [10] MECHANISM OF RESTORATION OF ACTH RELEASE IN RATS WITH LONG-TERM LESIONS OF THE PARAVENTRICULAR NUCLEI
    DOHANICS, J
    KAPOCS, G
    JANAKY, T
    KISS, JZ
    RAPPAY, G
    LASZLO, FA
    MAKARA, GB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1986, 111 (01) : 75 - 82